Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Bleda

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 13, 2018
Long-Term Effects of Bosentan on Cardiovascular Events in Hispanic Patients with Intermittent Claudication: Four-Year Follow-up of the CLAU Trial : The CLAU Randomized Trial Long-Term OutcomeJoaquin De Haro, Silvia Bleda, Carmen Gonzalez-Hidalgo, et al.
Journal of Vascular Surgery|July 22, 2014
Attenuation of early atherosclerotic lesions by immunotolerance with β2 glycoprotein I and the immunomodulatory effectors interleukin 2 and 10 in a murine modelJoaquin De Haro, Leticia Esparza, Silvia Bleda, et al.
Revista Espanola De Cardiologia|August 27, 2009
Selective cyclooxygenase-2 inhibition reduces endothelial dysfunction and improves inflammatory status in patients with intermittent claudicationAurora Flórez, Joaquín de Haro, Esther Martínez, et al.
Diabetes & Vascular Disease Research|November 9, 2011
Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patientsSilvia Bleda, Joaquin De Haro, Cesar Varela, et al.
Cholesterol|October 11, 2012
Improving Total-Cholesterol/HDL-Cholesterol Ratio Results in an Endothelial Dysfunction Recovery in Peripheral Artery Disease PatientsSilvia Bleda, Joaquín de Haro, César Varela, et al.
Cirugia Espanola|March 30, 2010
[Relationship between lower limb deep vein thrombosis and acute pulmonary and ischaemic upper limb thromboembolism: a case of a paradoxical embolism]Silvia Bleda Moreno, Joaquín De Haro Miralles, Aurora Flórez González, et al.
International Journal of Cardiology|January 21, 2014
NLRP1 inflammasome, and not NLRP3, is the key in the shift to proinflammatory state on endothelial cells in peripheral arterial diseaseSilvia Bleda, Joaquin de Haro, Cesar Varela, et al.
Therapeutic Advances in Chronic Disease|June 2, 2018
Carotid stenting with proximal cerebral protection in symptomatic low-grade vulnerable recurrent carotid stenosisJoaquin de Haro, Javier Rodriguez-Padilla, Silvia Bleda, et al.
Therapeutic Advances in Cardiovascular Disease|January 20, 2018
Differential mRNA expression of inflammasome genes NLRP1 and NLRP3 in abdominal aneurysmal and occlusive aortic diseaseCarmen Gonzalez-Hidalgo, Joaquin De Haro, Silvia Bleda, et al.
Journal of Vascular Surgery|May 4, 2012
Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of C-reactive protein plasma levelsJoaquin De Haro, Francisco Acin, Silvia Bleda, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 13, 2018
Long-Term Effects of Bosentan on Cardiovascular Events in Hispanic Patients with Intermittent Claudication: Four-Year Follow-up of the CLAU Trial : The CLAU Randomized Trial Long-Term OutcomeJoaquin De Haro, Silvia Bleda, Carmen Gonzalez-Hidalgo, et al.
Journal of Vascular Surgery|July 22, 2014
Attenuation of early atherosclerotic lesions by immunotolerance with β2 glycoprotein I and the immunomodulatory effectors interleukin 2 and 10 in a murine modelJoaquin De Haro, Leticia Esparza, Silvia Bleda, et al.
Revista Espanola De Cardiologia|August 27, 2009
Selective cyclooxygenase-2 inhibition reduces endothelial dysfunction and improves inflammatory status in patients with intermittent claudicationAurora Flórez, Joaquín de Haro, Esther Martínez, et al.
Diabetes & Vascular Disease Research|November 9, 2011
Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patientsSilvia Bleda, Joaquin De Haro, Cesar Varela, et al.
Cholesterol|October 11, 2012
Improving Total-Cholesterol/HDL-Cholesterol Ratio Results in an Endothelial Dysfunction Recovery in Peripheral Artery Disease PatientsSilvia Bleda, Joaquín de Haro, César Varela, et al.
Cirugia Espanola|March 30, 2010
[Relationship between lower limb deep vein thrombosis and acute pulmonary and ischaemic upper limb thromboembolism: a case of a paradoxical embolism]Silvia Bleda Moreno, Joaquín De Haro Miralles, Aurora Flórez González, et al.
International Journal of Cardiology|January 21, 2014
NLRP1 inflammasome, and not NLRP3, is the key in the shift to proinflammatory state on endothelial cells in peripheral arterial diseaseSilvia Bleda, Joaquin de Haro, Cesar Varela, et al.
Therapeutic Advances in Chronic Disease|June 2, 2018
Carotid stenting with proximal cerebral protection in symptomatic low-grade vulnerable recurrent carotid stenosisJoaquin de Haro, Javier Rodriguez-Padilla, Silvia Bleda, et al.
Therapeutic Advances in Cardiovascular Disease|January 20, 2018
Differential mRNA expression of inflammasome genes NLRP1 and NLRP3 in abdominal aneurysmal and occlusive aortic diseaseCarmen Gonzalez-Hidalgo, Joaquin De Haro, Silvia Bleda, et al.
Journal of Vascular Surgery|May 4, 2012
Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of C-reactive protein plasma levelsJoaquin De Haro, Francisco Acin, Silvia Bleda, et al.
Pageof 5